Aristo Bio-Tech & Lifescience Ltd (ARISTO) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Aristo Bio-Tech & Lifescience Ltd on NSE and BSE, with an AI summary of each filing.
Aristo Bio-Tech and Lifescience Limited has informed the Exchange about Board Meeting to be held on 14-Nov-2026 to inter-alia consider and approve the Unaudited Financial results of the Company for the Half Yearly ended September 2026 .
Intimation · 14 Nov 2026, 5:30 am
Aristo Bio-Tech Schedules Board Meeting for H1 FY27 Results Approval Aristo Bio-Tech and Lifescience Limited has notified the exchange that its Board of Directors is scheduled to meet on 14th Nov'26. The board will inter-alia consider, review, and approve the company's un-audited financial results for the half-year ended Sep'26.
To consider and approve the financial results for the period ended September 30, 2026 and other business matters
Intimation · 14 Nov 2026, 5:30 am
Aristo Bio-Tech Schedules Board Meeting for Half-Year Financial Results Aristo Bio-Tech and Lifescience Limited has scheduled a Board of Directors meeting on 14th Nov'26 to consider, approve, and take on record the unaudited standalone financial results for the half year ended 30th Sep'26. In accordance with insider trading regulations, the trading window for dealing in company securities has been closed since 1st Oct'26 and will remain closed until 48 hours after the declaration of the financial results.
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Re-Appointment of Ms. Rashmi Kamlesh Otavani as Non- Executive Independent Director of the company w.e.f. March 20, 2027.
Change in Management · 02 Oct 2026, 12:42 am
Aristo Bio-Tech Approves Director Re-Appointments at Annual General Meeting At its AGM on 30th Sep'26, Aristo Bio-Tech and Lifescience Limited approved the re-appointment of Mr. Ketankumar Harkantbhai Joshi as Whole Time Director for a five-year term effective 20th Mar'27. Shareholders also approved the re-appointment of Ms. Rashmi Kamlesh Otavani as Non-Executive Independent Director for a second five-year term effective 20th Mar'27. Neither appointee has relationships with other directors or is debarred by SEBI.
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Appointment of Mr Ketankumar Harkantbhai Modi as whole Time Director of the company w.e.f. March 20, 2027.
Change in Management · 02 Oct 2026, 12:38 am
Aristo Bio-Tech Approves Key Director Re-Appointments at AGM Aristo Bio-Tech and Lifescience Limited shareholders approved the re-appointment of Mr. Ketankumar Harkantbhai Joshi as Whole Time Director for a five-year term starting 20th Mar'27. Joshi, who also serves as Chief Financial Officer, brings over 28 years of agrochemical industry experience. Additionally, members approved the re-appointment of Ms. Rashmi Kamlesh Otavani as Non-Executive Independent Director for a second consecutive five-year term effective 20th Mar'27. Both resolutions were passed at the Annual General Meeting held on 30th Sep'26.
Aristo Bio-Tech And Lifescience Limited has submitted the Exchange a copy Srutinizers report of Annual General Meeting held on September 30, 2026. Further, the company has informed the Exchange regarding voting results.
Annual General Meeting · 02 Oct 2026, 12:19 am
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Proceedings of Annual General Meeting held on September 30, 2026.
Annual General Meeting · 01 Oct 2026, 12:57 am
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding 'Web-link of Annual Report for Financial Year 2025-26 to those Members who have not registered their e-mail addresses'.
Annual Report · 11 Sept 2026, 4:30 pm
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 30, 2026
Annual General Meeting · 09 Sept 2026, 2:33 am
Aristo Bio-Tech And Lifescience Limited has informed the Exchange that Record date for the purpose of Dividend is 23-Sep-2026.
Dividend · 08 Sept 2026, 1:48 am
Aristo Bio-Tech Sets Record Date for Final Dividend and Approves Board Re-appointments Aristo Bio-Tech and Lifescience Limited has fixed 23rd Sep'26 as the record date to determine shareholder eligibility for a final dividend of Rs. 0.60 per equity share (face value Rs. 10) for FY26. The company’s 21st AGM is scheduled for 30th Sep'26. Additionally, the Board approved the re-appointment of Ketankumar Harkantbhai Joshi as Whole Time Director and Rashmi Kamlesh Otavani as Non-Executive Independent Director, each for five years starting 20th Mar'27, alongside appointing M/s Y.S. Thakar & Co. as Cost Auditor for FY27.
Aristo Bio-Tech And Lifescience Limited has informed the Exchange regarding Outcome of Board Meeting held on September 07, 2026.
Outcome · 08 Sept 2026, 1:44 am
Aristo Bio-Tech Sets Dividend Record Date and Approves Key Board Re-Appointments Aristo Bio-Tech and Lifescience fixed 23rd Sep'26 as the record date for a final dividend of Rs. 0.60 per equity share (face value Rs. 10) for FY26. The 21st AGM is scheduled for 30th Sep'26. The board approved the re-appointment of Ketankumar Harkantbhai Joshi as Whole Time Director and Rashmi Kamlesh Otavani as Non-Executive Independent Director, both for five-year terms from 20th Mar'27 to 19th Mar'32. Additionally, M/s Y.S. Thakar & Co. was appointed as Cost Auditor for FY27.